Nasdaq · CIK 0000883975
MBOT Microbot Medical Inc.
Insider trading from SEC Form 4. Last filing Apr 3, 2026.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
5
with a Form 4 at this company
Signals
Open-market buys and sells at Microbot Medical Inc., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 10 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | Scott R Burell director | AGrant or award Stock Option (Right to Buy)derivative | +10,000 | $0.00 | $0 | 10,000 | Apr 3, 2026 |
| Feb 18, 2026 | Juan Diaz-Cartelle Chief Medical Officer | AGrant or award Stock Option (Right to Buy)derivative | +105,000 | $0.00 | $0 | 105,000 | Feb 20, 2026 |
| Feb 18, 2026 | Harel Gadot Chairman, President and CEO | AGrant or award Stock Option (Right to Buy)derivative | +480,000 | $0.00 | $0 | 480,000 | Feb 20, 2026 |
| Feb 18, 2026 | Simon Sharon General Manager, CTO | AGrant or award Stock Option (Right to Buy)derivative | +105,000 | $0.00 | $0 | 105,000 | Feb 20, 2026 |
| Feb 18, 2026 | Rachel Vaknin Chief Financial Officer | AGrant or award Stock Option (Right to Buy)derivative | +105,000 | $0.00 | $0 | 105,000 | Feb 20, 2026 |
| Feb 5, 2025 | Juan Diaz-Cartelle Chief Medical Officer | AGrant or award Stock Option (Right to Buy)derivative | +42,000 | $0.00 | $0 | 42,000 | Feb 7, 2025 |
| Feb 5, 2025 | Harel Gadot Chairman, President and CEO | AGrant or award Stock Option (Right to Buy)derivative | +228,000 | $0.00 | $0 | 228,000 | Feb 7, 2025 |
| Feb 26, 2024 | Juan Diaz-Cartelle Chief Medical Officer | AGrant or award Stock Option (Right to Buy)derivative | +10,500 | $0.00 | $0 | 10,500 | Feb 7, 2025 |
| Feb 26, 2024 | Harel Gadot Chairman, President and CEO | AGrant or award Stock Option (Right to Buy)derivative | +12,000 | $0.00 | $0 | 12,000 | Feb 7, 2025 |
| Jan 28, 2025 | Scott R Burell director | AGrant or award Stock Option (Right to Buy)derivative | +10,000 | $0.00 | $0 | 10,000 | Jan 30, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Scott R Burelldirector
- Juan Diaz-CartelleChief Medical Officer
- Harel GadotChairman, President and CEO
- Simon SharonGeneral Manager, CTO
- Rachel VakninChief Financial Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.